Regeneron Pharmaceuticals (REGN) was upgraded to a 'Buy' recommendation today by TheStreet.com's quantitative service. Let's check and see if the technical approach and the quantitative approach are on the same page.
More from Investing
The Fed doesn't know what will happen, and they most certainly don't know what they will do in response when the worm does indeed turn.
The market response will not be as simple as 'up on good news and down on bad news.'
Inflation will be a big theme for 2020 and commodities will benefit the most -- especially copper and iron-ore.
The Russell 2000 went from outperforming to underperforming on Wednesday; also, let's take a look at gold and bonds.
In a challenge to Broadcom and others, Cisco plans to sell a new switching/routing processor and license its routing software to other hardware makers.